Clinical and Molecular Hepatology  2017;23(3):219-221

doi:10.3350/cmh.2017.0045

Is tenofovir monotherapy a sufficient defense line against multi-drug resistant hepatitis B virus?.

Yun Bin LEE 1 ; Jeong Hoon LEE

Affiliations

+expand

Keywords

Chronic hepatitis B; Multi-drug resistance; Entecavir; Tenofovir; Rescue therapy

Country

Republic of Korea

Language

English

Abstract

No abstract available.